Inhibition of glioma cells in vitro and in vivo using a recombinant adenoviral vector containing an astrocyte-specific promoter

Cancer Gene Therapy

Volumn 7, Issue 8, 2000, Pages 1120-1126

  Vandier, Didier ^a   Rixe, Olivier ^b   Besnard, François ^c   Kim, Min ^d   Rikiyama, Toshiki ^a   Goldsmith, Merrill ^a   Brenner, Michael ^e   Gouyette, Alain ^f   Cowan, Kenneth H ^d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Clinique Claude Bernard   (France)

^c SANOFI   (France)

^d UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^e University of Alabama at Birmingham   (United States)

^f INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Adenovirus; Gene therapy; Glial fibrillary acidic protein; Glioblastoma; Herpes simplex virus thymidine kinase gene

Indexed keywords

GANCICLOVIR; GLIAL FIBRILLARY ACIDIC PROTEIN; THYMIDINE KINASE; VIRUS ENZYME; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CONTROLLED STUDY; DRUG ACTIVATION; GENE THERAPY; GLIOBLASTOMA; HERPES SIMPLEX VIRUS; MOUSE; MULTIMODALITY CANCER THERAPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALIA; CYTOMEGALOVIRUS; HERPES; MUS MUSCULUS; SIMPLEXVIRUS;

EID: 0033841598     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700211     Document Type: Article

References (30)

1. Intratumoral chemotherapy
2. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors
3. Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: An innovative approach for cancer therapy
4. Use of tissue-specific expression of the herpes simplex virus thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoral injection of DNA
5. Suicide gene expression induced in tumour cells transduced with recombinant adenoviral, retroviral, and plasmid vectors containing the ERBB2 promoter
6. Gene therapy for carcinoembryonic antigen-producing human lung cancer cells by cell type-specific expression of herpes simplex virus thymidine kinase gene
7. Immunohistochemistry of the glial fibrillary acidic protein: Basic and applied considerations
8. Aglial-specific, repressible, adenovirus vector for brain tumor gene therapy
9. Neuronal and glial cell type-specific promoters within adenovirus recombinants restrict the expression of the apoptosis-inducing molecule Fas ligand to predetermined brain cell types, and abolish peripheral liver toxicity
10. GFAP transgenic mice
11. Selective killing of glioma cell lines using an astrocyte-specific expression of the herpes simplex virus-thymidine kinase gene
12. Conditional ablation of cerebellar astrocytes in postnatal transgenic mice
13. Gene transfer in hepatocarcinoma cell lines: In vitro optimization of a virus-free system
14. Cytotoxic effects of adenovirus-mediated wild type p53 protein expression in normal and tumor mammary epithelial cells
15. New colorimetric cytotoxicity assay for anticancer-drug screening
16. Preclinical testing of recombinant adenoviral herpes simplex virus-thymidine kinase gene therapy for central nervous system malignancies
17. Gene therapy of central nervous system tumors
18. A phase I/II study of herpes simplex virus type 1 thymidine kinase 'suicide' gene therapy for recurrent glioblastoma
19. Gene therapy for treatment of recurrent glioblastoma multiforme with in vivo transduction using the herpes simplex-thymidine kinase gene/ganciclovir system
20. A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir
21. Regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors
22. Gene therapy for brain tumors: Regression of experimental gliomas by adenoviral-mediated gene transfer in vivo
23. Enhanced cytotoxicity of antiviral drugs mediated by adenovirus-directed transfer of the herpes simplex virus thymidine kinase gene in rat glioma cells
24. Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: A phase I trial
25. Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: Implications for clinical trials
26. Use of a liver-specific promoter reduces immune response to the transgene in adenoviral vectors
27. Glial fibrillary acidic protein (GFAP): The major protein of glial intermediate filaments in differentiated astrocytes
28. GFAP and astrogliosis
29. GFAP promoter directs astrocyte-specific expression in transgenic mice